Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure–activity relationship

Author： Katayama Kazuhiro   Masuyama Kazuto   Yoshioka Sho   Hasegawa Hitomi   Mitsuhashi Junko   Sugimoto Yoshikazu  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.60, Iss.6, 2007-11, pp. : 789-797

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Drug resistance in chemotherapy for breast cancer

By Saeki Toshiaki   Tsuruo Takashi   Sato Wakao   Nishikawsa Kiyoshiro  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 84-89

Springer Publishing Company

Access to resources Recommend Favorite

Flavonoids as Anticancer Agents: Structure-Activity Relationship Study

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 6, 2002-11 ,pp. : 691-714

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition - identification of novel chemotherapeutic drug resistance modulators

By Touhey S.   O'Connor R.   Plunkett S.   Maguire A.   Clynes M.  

European Journal of Cancer, Vol. 38, Iss. 12, 2002-08 ,pp. : 1661-1670

Elsevier

Access to resources Recommend Favorite

Side population cells and drug resistance in breast cancer

By      

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4297-4302

Spandidos Publications

Access to resources Recommend Favorite

Aberrant promoter DNA methylation inhibits bone morphogenetic protein 2 expression and contributes to drug resistance in breast cancer

By Du Min   Su XiaoMei   Zhang Tao   Xing YongJun  

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-08 ,pp. : 1051-1055

Spandidos Publications

Access to resources Recommend Favorite